<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00119002</url>
  </required_header>
  <id_info>
    <org_study_id>R40MC04298-01-00</org_study_id>
    <nct_id>NCT00119002</nct_id>
  </id_info>
  <brief_title>The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis</brief_title>
  <official_title>The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis: A Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helen DeVos Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women &amp; Children's Hospital of Buffalo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hurley Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Howard County General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare a single dose of oral dexamethasone to placebo in a multicenter,
      randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis
      (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any
      other routine therapy used at that center. No current standard therapy is withheld, and no
      additional tests or other treatments are part of the study.The primary hypothesis is that
      dexamethasone will be more effective than placebo in preventing hospital admission. The
      secondary hypotheses are that dexamethasone will decrease respiratory scores and possibly the
      duration of the disease when compared to placebo, and that dexamethasone will be as safe and
      as well tolerated as placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bronchiolitis is the most common lower respiratory infection in infants, and the respiratory
      condition leading to the most hospital admissions in young children. It is also probably the
      most common serious illness of childhood lacking evidence-based treatment. Evidence both for
      and against the effectiveness of corticosteroids such as dexamethasone has been published.
      Editorials, expert reviews, and a recent report from the Agency for Healthcare Research and
      Quality recommend a study such as this one.

      Patients will be drawn from the emergency departments at participating medical centers in the
      Pediatric Emergency Care Applied Research Network, created by the Emergency Medical Services
      for Children program and the Maternal and Child Health Bureau of the Health Resources and
      Services Administration to study health problems of high acuity and high incidence in
      children.

      Comparisons: The primary outcome (hospital admission after 4 hours of ED observation) and
      secondary outcomes will be compared between treatment and placebo groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">April 2006</completion_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital admission after 4 hours of ED observation</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of disease measured by respiratory (RDAI) scores, vital signs, and oximetry.</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization (if admitted) measured at 7-to-10 day followup.</measure>
    <time_frame>7-10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety, toleration, and parental satisfaction measured at 7-to-10 day followup.</measure>
    <time_frame>7-10 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">598</enrollment>
  <condition>Bronchiolitis, Viral</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1mg of Dexamethasone/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1mg/kg placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone</intervention_name>
    <description>1mg/kg dexamethasone</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1mg/kg placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First attack of wheezing within 7 days of onset

          -  Age 2 months through 11 months (less than 12 months)

          -  Disease of at least moderate severity (RDAI score greater than or equal to 6)

        Exclusion Criteria:

          -  Prior adverse reaction to dexamethasone

          -  Known heart or lung disease

          -  Premature birth prior to 36 weeks' gestation

          -  History of prior asthma or bronchodilator use

          -  Immune suppression or deficiency

          -  Trisomy 21

          -  Critical or life-threatening complications of bronchiolitis

          -  Treatment with corticosteroids within 14 days

          -  Known active chickenpox

          -  Exposure to chickenpox within 21 days

          -  Child sent to ED for automatic admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>11 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Corneli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Primary Children's Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84158-0249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pecarn.org</url>
    <description>Pediatric Emergency Care Applied Research Network (PECARN)</description>
  </link>
  <results_reference>
    <citation>Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD, Ruddy RM, Malik B, Nelson KA, Bregstein JS, Brown KM, Denenberg MN, Lillis KA, Cimpello LB, Tsung JW, Borgialli DA, Baskin MN, Teshome G, Goldstein MA, Monroe D, Dean JM, Kuppermann N; Bronchiolitis Study Group of the Pediatric Emergency Care Applied Research Network (PECARN). A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007 Jul 26;357(4):331-9. Erratum in: N Engl J Med. 2008 Oct 30;359(18):1972.. Majahan, Prashant [corrected to Mahajan, Prashant].</citation>
    <PMID>17652648</PMID>
  </results_reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2005</study_first_submitted>
  <study_first_submitted_qc>July 1, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2005</study_first_posted>
  <last_update_submitted>March 13, 2008</last_update_submitted>
  <last_update_submitted_qc>March 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Howard Corneli, MD Principal Investigator</name_title>
    <organization>University of Utah</organization>
  </responsible_party>
  <keyword>randomized clinical trial</keyword>
  <keyword>placebo-controlled</keyword>
  <keyword>double-blind</keyword>
  <keyword>double-masked</keyword>
  <keyword>infant</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>wheezing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis, Viral</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

